High levels of ABCB5 were associated with poor survival outcomes in HCC (Figure 3) and in diverse cancer types including low‐grade glioma, colon adenocarcinoma, prostate adenocarcinoma and stomach adenocarcinoma as shown in TCGA data sets (Figure S5). This evidence concerns the gene ABCB5 and hepatocellular carcinoma.